Rhapsido (remibrutinib) - Novartis
EVO756 - Evommune
ligelizumab (QGE031) - Novartis
Xolair (omalizumab) - Roche, Novartis
barzolvolimab (CDX-0159) - Celldex
briquilimab (JSP191) - Jasper Therapeutics
Dupixent (dupilumab) - Sanofi, Regeneron
Wayrilz (rilzabrutinib) - Sanofi
http://www.ncbi.nlm.nih.gov/pubmed/42770623
 
Davinder Parsad; Muthu Sendhil Kumaran; Sahibpreet Kaur; Saumya Singh
 
Sep 23, 2026
 
Prev Next